South Dakota 2022 Regular Session

South Dakota House Bill HB1027

Introduced
1/11/22  
Refer
1/12/22  
Report Pass
1/18/22  
Engrossed
1/19/22  
Refer
1/20/22  
Report Pass
1/26/22  
Enrolled
1/31/22  

Caption

Place certain substances on the controlled substances schedule and to declare an emergency.

Impact

The passage of HB 1027 would significantly affect the state's framework for managing controlled substances. By updating the controlled substances schedule, the bill allows state authorities to regulate the distribution and consumption of these new substances more strictly, thereby enhancing public health protections. Individuals and healthcare providers will need to adapt to these changes, which could result in increased scrutiny over prescriptions and potential changes in treatment protocols for affected medical conditions.

Summary

House Bill 1027 aims to amend the current controlled substances schedule in South Dakota by adding several specified substances to Schedule I. This bill was introduced in light of public health concerns, as these substances are often associated with high potential for abuse and addiction. By placing these substances under stricter regulatory controls, the bill is designed to enhance state efforts in combating substance abuse and ensuring public safety regarding the usage of controlled drugs.

Sentiment

Overall, the sentiment surrounding HB 1027 has been supportive among health advocates and law enforcement agencies, who view the bill as a necessary step towards addressing drug-related issues in South Dakota. There is recognition that adding these substances to the controlled list is a proactive approach to drug control. However, there are concerns among some healthcare providers regarding the implications for patient care, especially in terms of access to necessary medications that might fall under the new restrictions.

Contention

A notable point of contention surrounding the bill is the potential implications for legitimate medical use versus the intent to control abuse. Critics argue that while it is essential to regulate harmful substances, the bill could inadvertently restrict access to medications necessary for certain patient populations. Furthermore, the emergency nature of the bill's enactment means that discussions around its long-term implications and the necessary adjustments within the healthcare system might not be as thoroughly examined before its implementation.

Companion Bills

No companion bills found.

Similar Bills

SD SB35

Modify substances listed on the controlled substances schedule and to declare an emergency.

SD SB27

Place certain substances on the controlled substances schedule and to declare an emergency.

ND SB2093

The scheduling of controlled substances; and to declare an emergency.

ND SB2064

The scheduling of controlled substances; and to declare an emergency.

IN SB0209

Drug schedules.

HI HB1097

Relating To The Uniform Controlled Substances Act.

OK SB452

Uniform Controlled Dangerous Substances Act; including certain chemicals in the list of Schedule I substances. Effective date.

OK SB452

Uniform Controlled Dangerous Substances Act; including certain chemicals in the list of Schedule I substances. Effective date.